{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T16:04:02Z","timestamp":1779638642372,"version":"3.53.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,24]]},"DOI":"10.7759\/cureus.109545","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T15:19:21Z","timestamp":1779635961000},"source":"Crossref","is-referenced-by-count":0,"title":["Combination of the BK-Channel Antagonist ENA-001 and Naloxone Is More Effective Than Either Agent Alone in Reversing Fentanyl-Induced Respiratory Suppression in Rats"],"prefix":"10.7759","author":[{"given":"Monichan","family":"Phay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Kwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B","family":"Raffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph V","family":"Pergolizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-025-02284-z","article-title":"Polydrug overdose mortality caused by synthetic opioids and stimulants: current sex- and age-specific trajectories in United States national data for 2018-2024","volume":"51","author":"Butelman ER","year":"2026","unstructured":"Butelman ER, Huang Y, Shastry S, Manini AF, Goldstein RZ, Alia-Klein N. Polydrug overdose mortality caused by synthetic opioids and stimulants: current sex- and age-specific trajectories in United States national data for 2018-2024. Neuropsychopharmacology. 2026, 51:895-903. 10.1038\/s41386-025-02284-z","journal-title":"Neuropsychopharmacology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15573","article-title":"The anomalous pharmacology of fentanyl","volume":"180","author":"Kelly E","year":"2023","unstructured":"Kelly E, Sutcliffe K, Cavallo D, Ramos-Gonzalez N, Alhosan N, Henderson G. The anomalous pharmacology of fentanyl. Br J Pharmacol. 2023, 180:797-812. 10.1111\/bph.15573","journal-title":"Br J Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aen094","article-title":"Opioids and the control of respiration","volume":"100","author":"Pattinson KT","year":"2008","unstructured":"Pattinson KT. Opioids and the control of respiration. Br J Anaesth. 2008, 100:747-58. 10.1093\/bja\/aen094","journal-title":"Br J Anaesth"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2020.103388","article-title":"K\u00f6lliker-Fuse\/parabrachial complex mu opioid receptors contribute to fentanyl-induced apnea and respiratory rate depression","volume":"275","author":"Saunders SE","year":"2020","unstructured":"Saunders SE, Levitt ES. K\u00f6lliker-Fuse\/parabrachial complex mu opioid receptors contribute to fentanyl-induced apnea and respiratory rate depression. Respir Physiol Neurobiol. 2020, 275:103388. 10.1016\/j.resp.2020.103388","journal-title":"Respir Physiol Neurobiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/23247096211034036","article-title":"Wooden chest syndrome: a case report of fentanyl-induced chest wall rigidity","volume":"9","author":"Rosal NR","year":"2021","unstructured":"Rosal NR, Thelmo FL Jr, Tzarnas S, DiCalvo L, Tariq S, Grossman C. Wooden chest syndrome: a case report of fentanyl-induced chest wall rigidity. J Investig Med High Impact Case Rep. 2021, 9:10.1177\/23247096211034036","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.258566","article-title":"Noradrenergic mechanisms in fentanyl-mediated rapid death explain failure of naloxone in the opioid crisis","volume":"371","author":"Torralva R","year":"2019","unstructured":"Torralva R, Janowsky A. Noradrenergic mechanisms in fentanyl-mediated rapid death explain failure of naloxone in the opioid crisis. J Pharmacol Exp Ther. 2019, 371:453-75. 10.1124\/jpet.119.258566","journal-title":"J Pharmacol Exp Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00819.2021","article-title":"Effects of fentanyl overdose-induced muscle rigidity and dexmedetomidine on respiratory mechanics and pulmonary gas exchange in sedated rats","volume":"132","author":"Haouzi P","year":"2022","unstructured":"Haouzi P, Tubbs N. Effects of fentanyl overdose-induced muscle rigidity and dexmedetomidine on respiratory mechanics and pulmonary gas exchange in sedated rats. J Appl Physiol (1985). 2022, 132:1407-22. 10.1152\/japplphysiol.00819.2021","journal-title":"J Appl Physiol (1985)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181c38c25","article-title":"Incidence, reversal, and prevention of opioid-induced respiratory depression","volume":"112","author":"Dahan A","year":"2010","unstructured":"Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology. 2010, 112:226-38. 10.1097\/ALN.0b013e3181c38c25","journal-title":"Anesthesiology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2174\/138161212803582469","article-title":"Non-analgesic effects of opioids: opioid-induced respiratory depression","volume":"18","author":"Boom M","year":"2012","unstructured":"Boom M, Niesters M, Sarton E, Aarts L, Smith TW, Dahan A. Non-analgesic effects of opioids: opioid-induced respiratory depression. Curr Pharm Des. 2012, 18:5994-6004. 10.2174\/138161212803582469","journal-title":"Curr Pharm Des"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2023.2262386","article-title":"Pharmacology of viable mechanism agnostic respiratory stimulants for the reversal of drug-induced respiratory depression in humans","volume":"19","author":"van Lemmen M","year":"2023","unstructured":"van Lemmen M, van der Schrier R, Dahan A, van Velzen M, Sarton E, Niesters M. Pharmacology of viable mechanism agnostic respiratory stimulants for the reversal of drug-induced respiratory depression in humans. Expert Opin Drug Metab Toxicol. 2023, 19:671-9. 10.1080\/17425255.2023.2262386","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55057","article-title":"A  single ascending-dose study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel respiratory stimulant ENA-001","volume":"16","author":"Pergolizzi J Jr","year":"2024","unstructured":"Pergolizzi J Jr, Miller TL, Mathews J, Raffa RB, Colucci R, Diana FJ, Gould E. A  single ascending-dose study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel respiratory stimulant ENA-001. Cureus. 2024, 16:e55057. 10.7759\/cureus.55057","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeu182","article-title":"GAL-021, a new intravenous BKCa-channel blocker, is well tolerated and stimulates ventilation in healthy volunteers","volume":"113","author":"McLeod JF","year":"2014","unstructured":"McLeod JF, Leempoels JM, Peng SX, Dax SL, Myers LJ, Golder FJ. GAL-021, a new intravenous BKCa-channel blocker, is well tolerated and stimulates ventilation in healthy volunteers. Br J Anaesth. 2014, 113:875-83. 10.1093\/bja\/aeu182","journal-title":"Br J Anaesth"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1994.74.4.829","article-title":"Carotid body chemoreceptors: from natural stimuli to sensory discharges","volume":"74","author":"Gonzalez C","year":"1994","unstructured":"Gonzalez C, Almaraz L, Obeso A, Rigual R. Carotid body chemoreceptors: from natural stimuli to sensory discharges. Physiol Rev. 1994, 74:829-98. 10.1152\/physrev.1994.74.4.829","journal-title":"Physiol Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.99","article-title":"Reversal of opioid-induced respiratory depression by BK-channel blocker GAL021: a pharmacokinetic-pharmacodynamic modeling study in healthy volunteers","volume":"97","author":"Roozekrans M","year":"2015","unstructured":"Roozekrans M, Olofsen E, van der Schrier R, van Gerven J, Peng S, McLeod J, Dahan A. Reversal of opioid-induced respiratory depression by BK-channel blocker GAL021: a pharmacokinetic-pharmacodynamic modeling study in healthy volunteers. Clin Pharmacol Ther. 2015, 97:641-9. 10.1002\/cpt.99","journal-title":"Clin Pharmacol Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000367","article-title":"Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteers","volume":"121","author":"Roozekrans M","year":"2014","unstructured":"Roozekrans M, van der Schrier R, Okkerse P, Hay J, McLeod JF, Dahan A. Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteers. Anesthesiology. 2014, 121:459-68. 10.1097\/ALN.0000000000000367","journal-title":"Anesthesiology"},{"key":"ref16","article-title":"Central action of narcotic analgesics. I. Catalepsy and stereotypy in rats and narcotic analgesics","volume":"29","author":"Malec D","year":"1977","unstructured":"Malec D, Fidecka S, Langwi\u0144ski R. Central action of narcotic analgesics. I. Catalepsy and stereotypy in rats and narcotic analgesics. Pol J Pharmacol Pharm. 1977, 29:177-93.","journal-title":"Pol J Pharmacol Pharm"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(95)12049-a","article-title":"Involvement of potassium and calcium channels at the locus coeruleus in fentanyl-induced muscular rigidity in the rat","volume":"199","author":"Lee TY","year":"1995","unstructured":"Lee TY, Fu MJ, Lui PW, Chan SH. Involvement of potassium and calcium channels at the locus coeruleus in fentanyl-induced muscular rigidity in the rat. Neurosci Lett. 1995, 199:195-8. 10.1016\/0304-3940(95)12049-a","journal-title":"Neurosci Lett"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(89)90252-8","article-title":"Involvement of locus coeruleus and noradrenergic neurotransmission in fentanyl-induced muscular rigidity in the rat","volume":"96","author":"Lui PW","year":"1989","unstructured":"Lui PW, Lee TY, Chan SH. Involvement of locus coeruleus and noradrenergic neurotransmission in fentanyl-induced muscular rigidity in the rat. Neurosci Lett. 1989, 96:114-9. 10.1016\/0304-3940(89)90252-8","journal-title":"Neurosci Lett"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(90)90728-r","article-title":"Involvement of coerulospinal noradrenergic pathway in fentanyl-induced muscular rigidity in rats","volume":"108","author":"Lui PW","year":"1990","unstructured":"Lui PW, Lee TY, Chan SH. Involvement of coerulospinal noradrenergic pathway in fentanyl-induced muscular rigidity in rats. Neurosci Lett. 1990, 108:183-8. 10.1016\/0304-3940(90)90728-r","journal-title":"Neurosci Lett"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90744-7","article-title":"Involvement of g(o) alpha subtype of guanine nucleotide-binding regulatory protein at the locus coeruleus in fentanyl-induced muscular rigidity in the rat","volume":"165","author":"Fu MJ","year":"1994","unstructured":"Fu MJ, Lin TC, Lui PW, Lee TY, Chan SH. Involvement of g(o) alpha subtype of guanine nucleotide-binding regulatory protein at the locus coeruleus in fentanyl-induced muscular rigidity in the rat. Neurosci Lett. 1994, 165:199-202. 10.1016\/0304-3940(94)90744-7","journal-title":"Neurosci Lett"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1037\/\/0735-7044.102.5.748","article-title":"The catalepsy test: its ups and downs","volume":"102","author":"Sanberg PR","year":"1988","unstructured":"Sanberg PR, Bunsey MD, Giordano M, Norman AB. The catalepsy test: its ups and downs. Behav Neurosci. 1988, 102:748-59. 10.1037\/\/0735-7044.102.5.748","journal-title":"Behav Neurosci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2131","article-title":"Fentanyl-induced chest wall rigidity","volume":"143","author":"\u00c7oruh B","year":"2013","unstructured":"\u00c7oruh B, Tonelli MR, Park DR. Fentanyl-induced chest wall rigidity. Chest. 2013, 143:1145-6. 10.1378\/chest.12-2131","journal-title":"Chest"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.12703\/P6-79","article-title":"Opioid-induced respiratory depression: reversal by non-opioid drugs","volume":"6","author":"van der Schier R","year":"2014","unstructured":"van der Schier R, Roozekrans M, van Velzen M, Dahan A, Niesters M. Opioid-induced respiratory depression: reversal by non-opioid drugs. F1000Prime Rep. 2014, 6:79. 10.12703\/P6-79","journal-title":"F1000Prime Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.74826","article-title":"ENA-001 reverses xylazine\/fentanyl combination-induced respiratory depression in rats: a qualitative pilot study","volume":"16","author":"Miller TL","year":"2024","unstructured":"Miller TL, Mathews J, Dungan GC, Pergolizzi JV, Raffa RB. ENA-001 reverses xylazine\/fentanyl combination-induced respiratory depression in rats: a qualitative pilot study. Cureus. 2024, 16:e74826. 10.7759\/cureus.74826","journal-title":"Cureus"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000004915","article-title":"Reversal of propofol-induced depression of the hypoxic ventilatory response by BK-channel blocker ENA-001: a randomized controlled trial","volume":"140","author":"Jansen SC","year":"2024","unstructured":"Jansen SC, van Lemmen M, Olofsen E, et al.. Reversal of propofol-induced depression of the hypoxic ventilatory response by BK-channel blocker ENA-001: a randomized controlled trial. Anesthesiology. 2024, 140:1076-87. 10.1097\/ALN.0000000000004915","journal-title":"Anesthesiology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida RJ","year":"2006","unstructured":"Tallarida RJ. An overview of drug combination analysis with isobolograms. J Pharmacol Exp Ther. 2006, 319:1-7. 10.1124\/jpet.106.104117","journal-title":"J Pharmacol Exp Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)02271-6","article-title":"Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologram","volume":"58","author":"Tallarida RJ","year":"1996","unstructured":"Tallarida RJ, Raffa RB. Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologram. Life Sciences. 1996, 58:23-8. 10.1016\/0024-3205(95)02271-6","journal-title":"Life Sciences"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.149","article-title":"Analysis of drug combinations: current methodological landscape","volume":"3","author":"Foucquier J","year":"2015","unstructured":"Foucquier J, Guedj M. Analysis of drug combinations: current methodological landscape. Pharmacol Res Perspect. 2015, 3:e00149. 10.1002\/prp2.149","journal-title":"Pharmacol Res Perspect"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.067264","article-title":"Isobolographic analysis for combinations of a full and partial agonist: curved isoboles","volume":"310","author":"Grabovsky Y","year":"2004","unstructured":"Grabovsky Y, Tallarida RJ. Isobolographic analysis for combinations of a full and partial agonist: curved isoboles. J Pharmacol Exp Ther. 2004, 310:981-6. 10.1124\/jpet.104.067264","journal-title":"J Pharmacol Exp Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12055","article-title":"A search for interaction among combinations of drugs of abuse and the use of isobolographic analysis","volume":"38","author":"Tallarida RJ","year":"2013","unstructured":"Tallarida RJ, Midic U, Lamarre NS, Obradovic Z. A search for interaction among combinations of drugs of abuse and the use of isobolographic analysis. J Clin Pharm Ther. 2013, 38:190-5. 10.1111\/jcpt.12055","journal-title":"J Clin Pharm Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/479483-combination-of-the-bk-channel-antagonist-ena-001-and-naloxone-is-more-effective-than-either-agent-alone-in-reversing-fentanyl-induced-respiratory-suppression-in-rats","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T15:19:22Z","timestamp":1779635962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/479483-combination-of-the-bk-channel-antagonist-ena-001-and-naloxone-is-more-effective-than-either-agent-alone-in-reversing-fentanyl-induced-respiratory-suppression-in-rats"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,24]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.109545","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,24]]}}}